NCT00132392View on ClinicalTrials.gov

ALGRX 4975 After Total Knee Replacement

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 31, 2005

Study Completion Date

December 31, 2005

Conditions
Arthroplasty, Replacement, KneeKnee Injuries
Interventions
DRUG

ALGRX 4975

Trial Locations (1)

35209

Capstone Clinical Trials, Inc., Birmingham

Sponsors
All Listed Sponsors
lead

AlgoRx Pharmaceuticals

INDUSTRY

NCT00132392 - ALGRX 4975 After Total Knee Replacement | Biotech Hunter | Biotech Hunter